The question remains: what will it take to prove that any protection device is having a meaningful impact on stroke risk?
In the first head-to-head comparison of two devices intended to protect against stroke in patients undergoing transcatheter aortic valve replacement (TAVR), the investigational Emboliner device ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results